---
document_datetime: 2025-11-23 13:11:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/atryn.html
document_name: atryn.html
version: success
processing_time: 0.10641
conversion_datetime: 2025-12-24 08:40:37.520744
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# ATryn

[RSS](/en/individual-human-medicine.xml/66354)

##### Withdrawn

This medicine's authorisation has been withdrawn

antithrombin alfa

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on ATryn](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 22 December 2018, the European Commission withdrew the marketing authorisation for ATryn (antithrombin alfa) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Laboratoire Francais du Fractionnement et des Biotechnologies, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

ATryn was granted marketing authorisation in the EU on 28 July 2006 for prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency. The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2011. It was then granted unlimited validity in 2016. The product had not been marketed in the EU since 2015.

The European Public Assessment Report (EPAR) for ATryn is updated to indicate that the marketing authorisation is no longer valid.

ATryn : EPAR - Summary for the public

Reference Number: EMA/170731/2010

English (EN) (556.64 KB - PDF)

**First published:** 25/08/2009

**Last updated:** 02/07/2019

[View](/en/documents/overview/atryn-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-678)

български (BG) (638.56 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/bg/documents/overview/atryn-epar-summary-public_bg.pdf)

español (ES) (556.05 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/es/documents/overview/atryn-epar-summary-public_es.pdf)

čeština (CS) (621.61 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/cs/documents/overview/atryn-epar-summary-public_cs.pdf)

dansk (DA) (554.12 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/da/documents/overview/atryn-epar-summary-public_da.pdf)

Deutsch (DE) (559.1 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/de/documents/overview/atryn-epar-summary-public_de.pdf)

eesti keel (ET) (551.82 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/et/documents/overview/atryn-epar-summary-public_et.pdf)

ελληνικά (EL) (645.23 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/el/documents/overview/atryn-epar-summary-public_el.pdf)

français (FR) (557.59 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/fr/documents/overview/atryn-epar-summary-public_fr.pdf)

hrvatski (HR) (567.9 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/hr/documents/overview/atryn-epar-summary-public_hr.pdf)

italiano (IT) (554.23 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/it/documents/overview/atryn-epar-summary-public_it.pdf)

latviešu valoda (LV) (626.92 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/lv/documents/overview/atryn-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (582.09 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/lt/documents/overview/atryn-epar-summary-public_lt.pdf)

magyar (HU) (616.58 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/hu/documents/overview/atryn-epar-summary-public_hu.pdf)

Malti (MT) (626.53 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/mt/documents/overview/atryn-epar-summary-public_mt.pdf)

Nederlands (NL) (555.75 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/nl/documents/overview/atryn-epar-summary-public_nl.pdf)

polski (PL) (621.71 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/pl/documents/overview/atryn-epar-summary-public_pl.pdf)

português (PT) (557.12 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/pt/documents/overview/atryn-epar-summary-public_pt.pdf)

română (RO) (583.18 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/ro/documents/overview/atryn-epar-summary-public_ro.pdf)

slovenčina (SK) (623.24 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/sk/documents/overview/atryn-epar-summary-public_sk.pdf)

slovenščina (SL) (613.59 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/sl/documents/overview/atryn-epar-summary-public_sl.pdf)

Suomi (FI) (552.04 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/fi/documents/overview/atryn-epar-summary-public_fi.pdf)

svenska (SV) (554.92 KB - PDF)

**First published:**

25/08/2009

**Last updated:**

02/07/2019

[View](/sv/documents/overview/atryn-epar-summary-public_sv.pdf)

## Product information

ATryn : EPAR - Product Information

English (EN) (769.07 KB - PDF)

**First published:** 21/08/2009

**Last updated:** 02/07/2019

[View](/en/documents/product-information/atryn-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-491)

български (BG) (1.34 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/bg/documents/product-information/atryn-epar-product-information_bg.pdf)

español (ES) (761.38 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/es/documents/product-information/atryn-epar-product-information_es.pdf)

čeština (CS) (1.12 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/cs/documents/product-information/atryn-epar-product-information_cs.pdf)

dansk (DA) (765.5 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/da/documents/product-information/atryn-epar-product-information_da.pdf)

Deutsch (DE) (743.42 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/de/documents/product-information/atryn-epar-product-information_de.pdf)

eesti keel (ET) (743.52 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/et/documents/product-information/atryn-epar-product-information_et.pdf)

ελληνικά (EL) (1.37 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/el/documents/product-information/atryn-epar-product-information_el.pdf)

français (FR) (781.25 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/fr/documents/product-information/atryn-epar-product-information_fr.pdf)

hrvatski (HR) (914.47 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/hr/documents/product-information/atryn-epar-product-information_hr.pdf)

íslenska (IS) (765.23 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/is/documents/product-information/atryn-epar-product-information_is.pdf)

italiano (IT) (785.18 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/it/documents/product-information/atryn-epar-product-information_it.pdf)

latviešu valoda (LV) (1.16 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/lv/documents/product-information/atryn-epar-product-information_lv.pdf)

lietuvių kalba (LT) (850.35 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/lt/documents/product-information/atryn-epar-product-information_lt.pdf)

magyar (HU) (1.16 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/hu/documents/product-information/atryn-epar-product-information_hu.pdf)

Malti (MT) (1.3 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/mt/documents/product-information/atryn-epar-product-information_mt.pdf)

Nederlands (NL) (766.43 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/nl/documents/product-information/atryn-epar-product-information_nl.pdf)

norsk (NO) (744.22 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/no/documents/product-information/atryn-epar-product-information_no.pdf)

polski (PL) (1.14 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/pl/documents/product-information/atryn-epar-product-information_pl.pdf)

português (PT) (760.67 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/pt/documents/product-information/atryn-epar-product-information_pt.pdf)

română (RO) (940.03 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/ro/documents/product-information/atryn-epar-product-information_ro.pdf)

slovenčina (SK) (1.13 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/sk/documents/product-information/atryn-epar-product-information_sk.pdf)

slovenščina (SL) (1.17 MB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/sl/documents/product-information/atryn-epar-product-information_sl.pdf)

Suomi (FI) (763.61 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/fi/documents/product-information/atryn-epar-product-information_fi.pdf)

svenska (SV) (751.35 KB - PDF)

**First published:**

21/08/2009

**Last updated:**

02/07/2019

[View](/sv/documents/product-information/atryn-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0038 22/12/2018

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

ATryn : EPAR - All Authorised presentations

English (EN) (463.33 KB - PDF)

**First published:** 11/01/2007

**Last updated:** 02/07/2019

[View](/en/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_en.pdf)

[Other languages (22)](#file-language-dropdown-948)

български (BG) (554.27 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/bg/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_bg.pdf)

español (ES) (464.14 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/es/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_es.pdf)

čeština (CS) (540.06 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/cs/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (464.08 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/da/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (464.48 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/de/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (464.08 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/et/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (539.22 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/el/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_el.pdf)

français (FR) (463.71 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/fr/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (480.59 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/hr/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_hr.pdf)

italiano (IT) (463.6 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/it/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (544.13 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/lv/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (492.79 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/lt/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (505.6 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/hu/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (550.06 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/mt/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (463.49 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/nl/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_nl.pdf)

polski (PL) (543.57 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/pl/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_pl.pdf)

português (PT) (464.05 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/pt/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_pt.pdf)

română (RO) (536.52 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/ro/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (540.26 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/sk/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (475.65 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/sl/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (463.69 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/fi/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (464.01 KB - PDF)

**First published:**

11/01/2007

**Last updated:**

02/07/2019

[View](/sv/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine ATryn Active substance antithrombin alfa International non-proprietary name (INN) or common name antithrombin alfa Therapeutic area (MeSH) Antithrombin III Deficiency Anatomical therapeutic chemical (ATC) code B01AB02

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

ATryn is indicated for the prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency. ATryn is normally given in association with heparin or low molecular weight heparin.

## Authorisation details

EMA product number EMEA/H/C/000587

Exceptional circumstances

This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see [Pre-authorisation guidance](/node/68554) .

Marketing authorisation holder

Laboratoire Francais du Fractionnement et des Biotechnologies

3 Avenue des Tropiques

Marketing authorisation issued 28/07/2006 Withdrawal of marketing authorisation 22/12/2018 Revision 16

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

ATryn : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (573.02 KB - PDF)

**First published:** 21/08/2009

**Last updated:** 02/07/2019

[View](/en/documents/procedural-steps-after/atryn-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

ATryn : EPAR - Scientific Discussion

English (EN) (779.39 KB - PDF)

**First published:** 11/01/2007

**Last updated:** 02/07/2019

[View](/en/documents/scientific-discussion/atryn-epar-scientific-discussion_en.pdf)

ATryn : EPAR - Procedural steps taken before authorisation

English (EN) (480.68 KB - PDF)

**First published:** 11/01/2007

**Last updated:** 02/07/2019

[View](/en/documents/procedural-steps/atryn-epar-procedural-steps-taken-authorisation_en.pdf)

#### More information on ATryn

- [EMEA-001154-PIP01-11 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-001154-pip01-11)

**This page was last updated on** 02/07/2019

## Share this page

[Back to top](#main-content)